From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy: A detective story

Current Drug Targets: Immune, Endocrine and Metabolic Disorders

Volumn 5, Issue 3, 2005, Pages 323-329

  Miyata, Toshio ^a,b   Kurokawa, Kiyoshi ^a,b   van Ypersele de Strihou, Charles ^a,b  

^a TOKAI UNIVERSITY   (Japan)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Anti hypertensive agent; Carbonyl stress; Metabolic derangement; Oxidative stress; Protein modification advanced glycation end product; Renoprotection

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; CANDESARTAN; CAPTOPRIL; CARBOHYDRATE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; HYDRAZINE DERIVATIVE; IRBESARTAN; LOSARTAN; NIFEDIPINE; OLMESARTAN; PENTOSIDINE; PERINDOPRILAT; PYRIDOXAMINE; RAMIPRIL; TELMISARTAN; TEMOCAPRILAT; VALSARTAN;

ANTIOXIDANT ACTIVITY; BIOCHEMISTRY; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DRUG DOSE REGIMEN; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OXIDATIVE STRESS; PROTEIN FOOTPRINTING; PROTEIN MODIFICATION; PROTEINURIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIDE EFFECT;

ANIMALS; ANTIOXIDANTS; DIABETIC NEPHROPATHIES; DNA FOOTPRINTING; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; OXIDATIVE STRESS; RATS;

EID: 23644461957     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568008054863727     Document Type: Review

References (42)

1. Williamson, J.R.; Chang, K.; Frangos, M.; Hasan, K.S.; Ido, Y.; Kawamura, T.; Nyengaard, J.R.; van den Enden, M.; Kilo, C. and Tilton, R.G. (1993) Diabetes, 42, 801-813.
2. Bravi, M.C.; Pietrangeli, P.; Laurenti, O.; Basili, S.; Cassone-Faldetta, M.; Ferri, C. and De Mattia, G.. (1997) Metabolism, 46, 1194-1198.
3. Jennings, P.E.; Chirico, S.; Jones, A.F.; Lunec, J. and Barnett, A.H. Diabetes Res., 6, 151-154.
4. Suzuki, E.; Yasuda, K.; Takeda, N.; Sakata, S.; Era, S.; Kuwata, K.; Sogami, M. and Miura, K. (1992) Diabetes Res. Clin. Pract., 18, 153-158.
5. Miyata, T.; van Ypersele de Strihou, C.; Kurokawa, K. and Baynes, J.W. (1999) Kidney Int., 55, 389-99.
6. Wells-Knecht, M.C.; Lyons, T.J.; McCance, D.R.; Thorpe, S.R. and Baynes, J.W. (1997) J. Clin. Invest., 100, 839-846.
7. Horie, K.; Miyata, T.; Maeda, K.; Miyata, S.; Sugiyama, S.; Sakai, H.; van Ypersole de Strihou, C.; Monnier, V.M.; Witztum, J.L. and Kurokawa, K. (1997) J. Clin. Invest., 100, 2995-3004.
8. Sell, D.R. and Monnier, V.M. (1989) J. Biol. Chem., 264, 21597-21602.
9. Ahmed, M.U.; Thorpe, S.R. and Baynes, J.W. (1986) J. Biol. Chem., 261, 4889-4894.
10. Miyata, T.; Maeda, K.; Kurokawa, K. and van Ypersele de Strihou, C. (1997) Nephrol. Dial. Transplant, 12, 255-258.
11. Miyata, S. and Monnier, V.M. (1992) J. Clin. Invest., 89, 1102-1112.
12. Suzuki, D.; Miyata, T.; Saotome, N.; Horie, K.; Inagi, R.; Yasuda, Y.; Uchida, K.; Izuhara, Y.; Yagame, M.; Sakai, H. and Kurokawa, K. (1999) J. Am. Soc. Nephrol., 10, 822-832.
13. Pennathur, S.; Wagner, J.D.; Leeuwenburgh, C.; Litwak, K.N. and Heinecke, J.W. (2001) J. Clin. Invest., 107, 853-860.
14. Requena, J.R.; Fu, M.X.; Ahmed, M.U.; Jenkins, A.J.; Lyons, T.J.; Baynes, J.W. and Thorpe, S.R. (1997) Biochem. J., 322, 317-325.
15. Uchida, K.; Kanematsu, M.; Sakai, K.; Matsuda, T.; Hattori, N.; Mizuno, Y.; Suzuki, D.; Miyata, T.; Noguchi, N.; Niki, E. and Osawa, T. (1998) Proc. Natl. Acad. Sci. USA, 95, 4882-4887.
16. Hazen, S.L.; Hsu, F.F.; Mueller, D.M.; Crowley, J.R. and Heinecke, J.W. (1996) J. Clin. Invest., 8, 1283-1289.
17. Ischiropoulos, H. and al-Mehdi, A.B. (1995) FEBS Lett., 364, 279-282.
18. Onozato, M.L.; Tojo, A.; Goto, A.; Fujita, T. and Wilcox, C.S. (2002) Kidney Int., 61, 186-194.
19. Young, B.A.; Johnson, R.J.; Alpers, C.E.; Eng, E.; Gordon, K.; Floege, J.; Couser, W.G. and Seidel, K. (1995) Kidney Int., 47, 935-944.
20. Sugimoto, H.; Shikata, K.; Hirata, K.; Akiyama, K.; Matsuda, M.; Kushiro, M.; Shikata, Y.; Miyatake, N.; Miyasaka, M. and Makino, H. (1997) Diabetes, 46, 2075-2081.
21. Okada, S.; Shikata, K.; Ogawa, D.; Usui, H.; Matsuda, M.; Wada, J. and Makino, H. (2001) Diabetes, 50, A63-64.
22. Brownlee, M.; Vlassara, H.; Kooney, A., Ulrich, P. and Cerami, A. (1986) Science, 232, 1629-1632.
23. Nakamura, S.; Makita, Z.; Ishikawa, S.; Yasumura, K.; Fujii, W.; Yanagisawa, K.; Kawata, T. and Koike, T. (1997) Diabetes, 46, 895-899.
24. Miyata, T.; Ueda, Y.; Asahi, K.; Izuhara, Y.; Inagi, R.; Saito, A.; Van Ypersele de Strihou, C. and Kurokawa, K. (2000) J. Am. Soc. Nephrol., 11, 1719-1725.
25. Miyata, T.; Ueda, Y.; Yamada, Y.; Izuhara, Y.; Wada, T.; Jadoul, M.; Saito, A.; Kurokawa, K. and van Ypersele de Strihou, C. (1998) J. Am. Soc. Nephrol., 9, 2349-2356.
26. Miyata, T.; Horie, K.; Ueda, Y.; Fujita, Y.; Izuhara, Y.; Hirano, H.; Uchida, K.; Saito, A.; van Ypersele de Strihou, C. and Kurokawa, K. (2000) Kidney Int., 58, 425-435.
27. Akhand, A.A.; Kato, M.; Suzuki, H.; Liu, W.; Du, J.; Hamaguchi, M.; Miyata, T.; Kurokawa, K. and Nakashima, I. (1999) J. Cell Biochem., 72, 1-7.
28. Miyata, T.; Ishikawa, S.; Asahi, K.; Inagi, R.; Suzuki, D.; Horie, K.; Tatsumi, K. and Kurokawa, K. (1999) FEBS lett., 445, 202-206.
29. Taguchi, T.; Sugiura, M., Hamada, Y., Miwa, I. Biochem. Pharmacol., 55, 1667-1671.
30. Miyata, T.; van Ypersele de Strihou, C.; Ueda, Y.; Ichimori, K.; Inagi, R.; Onogi, H.; Ishikawa, N.; Nangaku, M. and Kurokawa, K. (2002) J. Am. Soc. Nephrol., 13, 2478-2487.
31. Degenhardt, T.P.; Alderson, N.L.; Arrington, D.D.; Beattie, R.J.; Basgen, J.M.; Steffes, M.W.; Thorpe, S.R. and Baynes, J.W. (2002) Kidney Int., 61, 939-950.
32. Nangaku, M.; Miyata, T.; Sada, T.; Mizuno, M.; Inagi, R.; Ueda, Y.; Ishikawa, N.; Yuzawa, H.; Koike, H.; van Ypersele de Strihou, C. and Kurokawa, K. J. Am. Soc. Nephrol., 14, 1212-1222.
33. Patrick, D.H.; Hansen, C.T.; Canary, J.J.; Werner, R.M. and Carswell, N. Am. J. Pathol., 123, 398-400.
34. Forbes, J.M.; Cooper, M.E.; Thallas, V.; Burns, W.C.; Thomas, M.C.; Brammar, G..C.; Lee, F.; Grant, S.L.; Burrell, L.A.; Jerums, G. and Osicka, T.M. (2002) Diabetes, 51, 3274-3282.
35. Wilkinson-Berka, J.L.; Kelly, D.J.; Koerner, S.M.; Jaworski, K.; Davis, B.; Thallas, V. and Cooper, M.E. (2002) Diabetes, 51, 3283-3289.
36. Soulis-Liparota, T.; Cooper, M.; Papazoglou, D.; Clarke, B. and Jerums, G. (1991) Diabetes, 40, 1328-1334.
37. Parving, H.H.; Hommel, E.; Jensen, B.R. and Hansen, H.P. (2001) Kidney Int., 60, 228-234.
38. Brenner, B.M.; Cooper, M.E.; de Zeeuw, D.; Keane, W.F.; Mitch, W.E.; Parving, H.H.; Remuzzi, G.; Snapinn, S.M.; Zhang, Z. and Shahinfar, S. (2002) N. Engl. J. Med., 345, 861-869.
39. Viberti, G. and Wheeldon, N.M. (2000) Circulation, 106, 672-678.
40. Heart outcomes prevention evaluation (HOPE) study investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. (2000) Lancet, 355, 253-59.
41. Pitt, B.; Poole-Wilson, P.A.; Seoul, R.; Martinez, F.A.; Dickstein, K.; Camon, A.J.; Konstam, M.A.; Riegger, G.; Klinger, G.H.; Neaton, J.; Sharma, D. and Thiyagarajan, B. (2000) Lancet, 355, 1582-87.
42. Weinberg, M.S.; Weiberg, A.J.; Cord, R. and Zappe, D.H. (2001) J. Renin Angiotensin Aldosterone Syst., 2(suppl. 1), S196-S198.